1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd.

KMTS
Kestra Medical Technologies, Ltd.US flagNASDAQ Global Select
27.31
USD
-0.97
- -
1.63BMarket Cap

Total Valuation

Kestra Medical Technologies, Ltd. carries a market capitalization of 1.63B, placing it among publicly traded companies globally. Its enterprise value stands at 1.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.63B
Enterprise Value1.23B

Share Statistics

Kestra Medical Technologies, Ltd. currently has 59.27M shares outstanding.

Shares Outstanding59.27M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 11.99, and the price-to-book ratio stands at 6.09.

PE RatioN/A
PS Ratio11.99
PB Ratio6.09
P/TBV Ratio6.09
P/FCF Ratio-24.49
P/OCF Ratio-14.59

Enterprise Valuation

EV / Sales11.53
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Kestra Medical Technologies, Ltd. maintains a current ratio of 4.69, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.38, indicating elevated leverage, while an interest coverage ratio of -17.74 demonstrates limited ability to service its debt obligations.

Current Ratio4.69
Quick Ratio4.44
Debt / Equity34.38
Debt / EBITDA-0.57
Interest Coverage-17.74

Financial Efficiency

Return on Equity (ROE)-73.74
Return on Assets (ROA)-48.85
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.91

Taxes

Income Tax311,000.00
Effective Tax RateN/A

Stock Price Statistics

Kestra Medical Technologies, Ltd.'s stock has gained approximately 3.44697% over the past 52 weeks. The 50-day moving average sits at 26.46, while the 200-day moving average is 23.62.

Beta (5Y)N/A
52-Week Price Change3.44697%
50-Day Moving Average26.46
200-Day Moving Average23.62
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kestra Medical Technologies, Ltd. generated 106.73M in revenue and converted that into -149.87M in net income, yielding earnings per share of -2.67. EBITDA reached -134.18M, while operating income came in at -143.52M.

Revenue106.73M
Gross Profit57.51M
Operating Income-143.52M
Pretax Income-149.56M
Net Income-149.87M
EBITDA-134.18M
EBIT-143.52M
Earnings Per Share (EPS)-2.67

Balance Sheet

Kestra Medical Technologies, Ltd. holds 198.91M in cash and equivalents against 76.45M in total debt, resulting in a net debt position of 3.94M. Total book value stands at 222.36M, with working capital of 178.00M providing operational flexibility.

Cash & Cash Equivalents198.91M
Total Debt76.45M
Net Debt3.94M
Equity (Book Value)222.36M
Book Value Per Share3.75
Working Capital178.00M

Cash Flow

Kestra Medical Technologies, Ltd. produced -87.72M in operating cash flow over the past twelve months. After subtracting -35.49M in capital expenditures, free cash flow totaled -123.21M - equivalent to -2.20 per share.

Operating Cash Flow-87.72M
Capital Expenditures-35.49M
Free Cash Flow-123.21M
FCF Per Share-2.20

Margins

Kestra Medical Technologies, Ltd. operates with a gross margin of 53.89, reflecting its pricing power and cost economics. The operating margin of -134.48 and net profit margin of -140.43 provide insight into operational efficiency.

Gross Margin53.89
Operating Margin-134.48
Pretax Margin-140.14
Profit Margin-140.43
EBITDA Margin-125.72

Dividends & Yields

The company's payout ratio of -0.33 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio-0.33
Shareholder Yield-12.67
FCF Yield-4.08

Scores

Kestra Medical Technologies, Ltd. posts an Altman Z-Score of 3.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.25